Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Unknown 2Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 6Esophageal Squamous Cell Carcinoma 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Medulloblastoma 1Locally Advanced Rectal Carcinoma 1High-Risk Cancer 1Fallopian Tube Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Cancer Metastatic 1Breast Cancer Invasive 1

Interventions

Tamoxifen 3Radiotherapy 3Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Radiation 2Observation 2Metformin 2pembrolizumab 1exemestane 1afimoxifene 1Tablets 1Surgical Procedures, Operative 1Steroids 1Specimen Handling 1Protons 1Proton Therapy 1Petrolatum 1Nutrition Assessment 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Mammography 1Magnetic Resonance Spectroscopy 1Letrozole 1Biopsy, Needle 1Biopsy, Large-Core Needle 1Anastrozole 14,17 beta-dihydroxy-4-androstene-3-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Intraductal, Noninfiltrating × Neoadjuvant Therapy × Clear all
NCT01272037 2026-06-03

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
5,018 enrolled 14 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡